Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma
Clinical trial NCT04792073 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04792073
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-08
- Primary completion
- 2027-03-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.